21 research outputs found
Increasing Student Comfort with Addressing Microaggressions: Ouch! That Stereotype Hurts
Students on college campuses are not prepared or equipped to defend themselves or their peers when they experience or witness a microaggression. The purpose of this study was to measure the impact of the Ouch! That Stereotype Hurts program on s tudent comfort level when addressing microaggressions and other gender, racial and cultural insults. This educational program provides examples of different types of microaggressions seen in classrooms and workplace scenarios. The program is a 30 minute in dividual, self paced, guided eLearning program that enables learners to explore communication skills for promoting inclusion and respect among their peers. Participants were 91 undergraduate students (primarily White women) attending a mid south university enrolled in a 3 hour online general elective course in Fall 2020 or Spring 2021. Students completed a pre assessment in the 5th week of classes, and the Ouch! 30 minute training program and post assessment the following week. On average, students\u27 knowled ge did not change; however, students\u27 comfort level did increase significantly: On average, 50% of students reported feeling comfortable addressing microaggressions, which increased to 95% of students after completing the 30 minute Ouch! program. The prese nt study\u27s participants were primarily White students living in the mid south. This research indicates that students, especially those who identify as White, would benefit in their comfort level when exposed to diversity educational training on a college c ampus. Keywords: stereotypes, microaggressions, training, higher education
Developing Cultural Competence among 4-H Leaders
Access, equity, diversity, and inclusion are essential elements of 4-Hâs goals related to positive youth development and organizational sustainability. The 4-H organization has impacted over 6 million youth worldwide and continues to grow every day. At the county, state, and national level, 4-H programs have grown more diverse, making it essential that 4-H programs encourage and highlight cultural similarities and differences through education. However, training in cultural competence for 4-H leaders is lacking, which is the bridge to connecting diversity and inclusion. Cultural competency is an awareness of oneâs own cultural identity and the ability to interact effectively and appropriately with people from other cultures. This project utilized a multidisciplinary and collaborative effort to deliver cultural competence training for 27 4-H young adult and adult leaders in a mid-South U.S. state. All participants completed pre-assessments of the Intercultural Development Inventory (IDI), participated in 2-hour training sessions on cultural competence, and completed post-IDI assessments three months later. Overall, most 4-H leaders scored in the Minimization orientation, which is the most common orientation among adults. In order to advance beyond the Minimization orientation to the Acceptance orientation, 4-H educators need additional educational opportunities, which may aid them in understanding crucial differences between cultures. The cultural competency model of the IDI provides a valuable framework in preparing culturally sensitive 4-H educators to construct settings where equity, access, and opportunity are available to all youth, allowing 4-H members to better reach their potential as capable, caring, and competent leaders of today and tomorrow
A large-scale genome-wide association study meta-analysis of cannabis use disorder
Summary Background Variation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50â70%) and is associated with negative outcomes, including increased risk of psychopathology. The aim of the study was to conduct a large genome-wide association study (GWAS) to identify novel genetic variants associated with cannabis use disorder. Methods To conduct this GWAS meta-analysis of cannabis use disorder and identify associations with genetic loci, we used samples from the Psychiatric Genomics Consortium Substance Use Disorders working group, iPSYCH, and deCODE (20â916 case samples, 363â116 control samples in total), contrasting cannabis use disorder cases with controls. To examine the genetic overlap between cannabis use disorder and 22 traits of interest (chosen because of previously published phenotypic correlations [eg, psychiatric disorders] or hypothesised associations [eg, chronotype] with cannabis use disorder), we used linkage disequilibrium score regression to calculate genetic correlations. Findings We identified two genome-wide significant loci: a novel chromosome 7 locus (FOXP2, lead single-nucleotide polymorphism [SNP] rs7783012; odds ratio [OR] 1·11, 95% CI 1·07â1·15, p=1·84âĂâ10â9) and the previously identified chromosome 8 locus (near CHRNA2 and EPHX2, lead SNP rs4732724; OR 0·89, 95% CI 0·86â0·93, p=6·46âĂâ10â9). Cannabis use disorder and cannabis use were genetically correlated (rg 0·50, p=1·50âĂâ10â21), but they showed significantly different genetic correlations with 12 of the 22 traits we tested, suggesting at least partially different genetic underpinnings of cannabis use and cannabis use disorder. Cannabis use disorder was positively genetically correlated with other psychopathology, including ADHD, major depression, and schizophrenia. Interpretation These findings support the theory that cannabis use disorder has shared genetic liability with other psychopathology, and there is a distinction between genetic liability to cannabis use and cannabis use disorder. Funding National Institute of Mental Health; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing; The European Commission, Horizon 2020; National Institute of Child Health and Human Development; Health Research Council of New Zealand; National Institute on Aging; Wellcome Trust Case Control Consortium; UK Research and Innovation Medical Research Council (UKRI MRC); The Brain & Behavior Research Foundation; National Institute on Deafness and Other Communication Disorders; Substance Abuse and Mental Health Services Administration (SAMHSA); National Institute of Biomedical Imaging and Bioengineering; National Health and Medical Research Council (NHMRC) Australia; Tobacco-Related Disease Research Program of the University of California; Families for Borderline Personality Disorder Research (Beth and Rob Elliott) 2018 NARSAD Young Investigator Grant; The National Child Health Research Foundation (Cure Kids); The Canterbury Medical Research Foundation; The New Zealand Lottery Grants Board; The University of Otago; The Carney Centre for Pharmacogenomics; The James Hume Bequest Fund; National Institutes of Health: Genes, Environment and Health Initiative; National Institutes of Health; National Cancer Institute; The William T Grant Foundation; Australian Research Council; The Virginia Tobacco Settlement Foundation; The VISN 1 and VISN 4 Mental Illness Research, Education, and Clinical Centers of the US Department of Veterans Affairs; The 5th Framework Programme (FP-5) GenomEUtwin Project; The Lundbeck Foundation; NIH-funded Shared Instrumentation Grant S10RR025141; Clinical Translational Sciences Award grants; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences.Peer reviewe
Shared genetic risk between eating disorder- and substance-use-related phenotypes:Evidence from genome-wide association studies
First published: 16 February 202
A large-scale genome-wide association study meta-analysis of cannabis use disorder
Background: Variation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50-70%) and is associated with negative outcomes, including increased risk of psychopathology. The aim of the study was to conduct a large genome-wide association study (GWAS) to identify novel genetic variants associated with cannabis use disorder.
Methods: To conduct this GWAS meta-analysis of cannabis use disorder and identify associations with genetic loci, we used samples from the Psychiatric Genomics Consortium Substance Use Disorders working group, iPSYCH, and deCODE (20 916 case samples, 363 116 control samples in total), contrasting cannabis use disorder cases with controls. To examine the genetic overlap between cannabis use disorder and 22 traits of interest (chosen because of previously published phenotypic correlations [eg, psychiatric disorders] or hypothesised associations [eg, chronotype] with cannabis use disorder), we used linkage disequilibrium score regression to calculate genetic correlations.
Findings: We identified two genome-wide significant loci: a novel chromosome 7 locus (FOXP2, lead single-nucleotide polymorphism [SNP] rs7783012; odds ratio [OR] 1·11, 95% CI 1·07-1·15, p=1·84 à 10-9) and the previously identified chromosome 8 locus (near CHRNA2 and EPHX2, lead SNP rs4732724; OR 0·89, 95% CI 0·86-0·93, p=6·46 à 10-9). Cannabis use disorder and cannabis use were genetically correlated (rg 0·50, p=1·50 à 10-21), but they showed significantly different genetic correlations with 12 of the 22 traits we tested, suggesting at least partially different genetic underpinnings of cannabis use and cannabis use disorder. Cannabis use disorder was positively genetically correlated with other psychopathology, including ADHD, major depression, and schizophrenia.
Interpretation: These findings support the theory that cannabis use disorder has shared genetic liability with other psychopathology, and there is a distinction between genetic liability to cannabis use and cannabis use disorder
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
Liability to alcohol dependence (AD) is heritable, but little is known about its complex polygenic architecture or its genetic relationship with other disorders. To discover loci associated with AD and characterize the relationship between AD and other psychiatric and behavioral outcomes, we carried out the largest genome-wide association study to date of DSM-IV-diagnosed AD. Genome-wide data on 14,904 individuals with AD and 37,944 controls from 28 case-control and family-based studies were meta-analyzed, stratified by genetic ancestry (European, n = 46,568; African, n = 6,280). Independent, genome-wide significant effects of different ADH1B variants were identified in European (rs1229984; P = 9.8 x 10(-13)) and African ancestries (rs2066702; P = 2.2 x 10(-9)). Significant genetic correlations were observed with 17 phenotypes, including schizophrenia, attention deficit-hyperactivity disorder, depression, and use of cigarettes and cannabis. The genetic underpinnings of AD only partially overlap with those for alcohol consumption, underscoring the genetic distinction between pathological and nonpathological drinking behaviors.Peer reviewe
P654: Genetic counselor involvement increases the uptake and success of familial studies in variant re-classification for disorders of hemostasis
Recommended from our members
Using Mobile Technologies for Assessment and Learning in Practice Settings: Outcomes of Five Case Studies
N